% | $
Quotes you view appear here for quick access.

Cancer Genetics, Inc. Message Board

  • biotuesday biotuesday Jul 23, 2013 8:26 AM Flag

    BioTuesdays - In conversation with Panna Sharma

    As CEO of Cancer Genetics (OTCQB:CGIX), Panna Sharma was attracted to the emerging leader in DNA-based cancer diagnostics and services by its rich heritage in understanding genetic changes and aberrations that have clinical value. A former managing partner and founder of TSG Partners, a specialty life sciences consultancy and advisory company, Mr. Sharma led the development of strategic initiatives, corporate growth strategy and corporate turnarounds for both public and private companies. He also led over 70 buy and sell-side transactions in the healthcare sector. At TSG, he established the Global Diagnostics Index, the Global Biotools Index and several other life science capital markets indices that are still used today. In this interview, Mr. Sharma discusses how molecular diagnostics is changing the vision of personalized medicine and how Cancer Genetics’ products and services are tailored to the specific genetic profile of the individual to better diagnose and guide treatment decisions in hematologic and urogenital cancers.

    See BT for full feature interview

2.18+0.11(+5.31%)1:55 PMEST